As a Fenton reagent, iron nitroprusside, (FeNP) has a therapeutic effect on ovarian cancer organs originating from high-grade serous ovarian carcinoma (HGSOC) by inhibiting GPX4’s involvement in ferroptosis (95) (Table 2). The gene discussed is GPX4; the disease is ovarian cancer.